^
    over1year
    Follicular lymphoma -- BCL-2 overexpression (@AyasunMDPhD)
    IO biomarker
    |
    BCL2 (B-cell CLL/lymphoma 2)
    |
    BCL2 overexpression
    over2years
    #ASH21 #leusm Diaz-Flores: CD22 low / BCL2 high expression associated with poor response to Inotuzumab. This study used samples from COG AALL1621, age 1-21 (@hemedoc)
    IO biomarker
    |
    BCL2 (B-cell CLL/lymphoma 2) • CD22 (CD22 Molecule)
    |
    BCL2 overexpression • BCL2 expression
    |
    Besponsa (inotuzumab ozogamicin)